about
Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials.Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value.Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment.Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the InternetAssessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI gradeQuality of life implications of bisphosphonate-associated osteonecrosis of the jaw.Determinants and outcomes of adherence to recommendations from a multidisciplinary tumour conference for hepatocellular carcinomaComparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's diseaseStereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma.From treatment to prevention: the interplay between HIV/AIDS treatment availability and HIV/AIDS prevention programming in Khayelitsha, South AfricaCost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria.Progression-free survival as a surrogate endpoint in advanced breast cancerStereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer.A genomic case study of mixed fibrolamellar hepatocellular carcinomaUtility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancerMeasuring the quality-of-life effects of diagnostic and screening tests.What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?Cabozantinib in the treatment of hepatocellular carcinoma.Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy.Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry.Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis.Cutting Through Confusion: Multimodality Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer.Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer.Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer.Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient.Hepatic hydrothorax associated with vitamin a toxicity.A comparison of surgical outcomes for noncirrhotic and cirrhotic hepatocellular carcinoma patients in a Western institutionWhen a Decision Must Be Made: Role of Computer Modeling in Clinical Cancer ResearchInduction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas CancerSafety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled TrialsDETECTION OF PROSTATE CANCER FOLLOWING GENDER REASSIGNMENT
P50
Q31060752-E06A5593-934E-4EEA-8EC8-37124014BEE6Q33384665-881016CC-A8B6-4F3A-8D8E-3CBE2D593829Q33392652-D53E7790-0648-4DFC-A7AE-E394BEC05B9AQ33402226-88BD33B4-9E30-4C95-B73B-614A38431CC1Q34504649-AEC92901-ECA5-48D7-A7A2-06D13948D27CQ34520716-77E3A167-847F-4CF7-A196-C8C23A93BC4AQ34592887-2861E87E-3953-4FA0-B55D-84AAC95B6CF0Q35065472-007485F6-D1BF-4A0E-8F0A-4F36E29BA610Q35584343-27DE1FE2-3007-463E-B702-EB5FD54307C0Q35805862-C17B73E3-BE29-4161-8AD8-056AAD7FC6B6Q36055027-C3827056-ED43-4CB5-8AC1-F4D6BEFC11ABQ36190116-F97C6C3F-9D89-4B61-9E98-FC13DE5F2403Q36272757-7C08E5F0-A0F9-41D8-A8E5-273AAC5957C0Q36339076-714445D8-A7C7-4072-B791-47EE464C7421Q36552307-C6F0806F-6F9E-4415-9A0B-65C93AF16D14Q36563900-683EA474-5F11-4483-B965-06B1DFB50B9CQ36935210-06D1F6CA-5B9E-4DFA-9FAA-12D63ED6388CQ37251564-AF92FD5E-4D5A-4C1A-B20A-6A4CFBA3280CQ37566956-7393B493-C98D-4C51-8BBD-CD579F811BCBQ37895616-63C28BF2-F1A4-4BB2-837B-651E8D1EE93EQ38658285-70289CAC-BF39-4494-8ED2-1108A245E234Q38795461-0B57CAED-9AE8-4B0D-B506-7CEA2A33E71CQ38796356-08183548-05F4-45BD-9A75-FB23B1C76F99Q38894345-28ACEEEC-256E-40A2-8BC0-526CF4C272C9Q39445235-39C031EF-D840-49B5-96F8-200D97ADE687Q41651225-42B76E83-915A-4BD1-8AAE-A09DEDAFCB84Q42216727-978DAE5A-9803-4E85-8A48-AC06541BC8BFQ42273555-4888A041-7663-4B26-AD12-2829547D35B7Q42690907-E53C9258-C332-460C-8CA1-25346D72B9F4Q43155768-F574A238-7723-4C50-869A-A5220D8BA10DQ46065007-459E449F-792A-4AA1-BBB9-04663DA4AAB2Q46974051-CDEC35F4-D266-453D-8507-405A6D8D79E9Q47588606-F1DB6D5B-17C3-4D91-B845-916C284C6449Q50725721-D465EE11-8241-40FE-8007-5F3BCCFD1C14Q51725496-332A90C5-0A20-44F1-9A52-063010049201Q63197286-E00B8CA2-F274-47DF-BA8F-B17A8F474B07Q63197287-9536A72E-FB2D-47A2-84D1-F025D6D3A972Q63197288-0FBEBF3F-EC65-49A6-A833-1D49232A8CAEQ63197289-41BAAEE3-7D55-467F-A6FF-E08E55BE629EQ63197292-2F34DDB9-C0EC-4C2E-87E3-8ECCDF1BEF92
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rebecca Miksad
@ast
Rebecca Miksad
@en
Rebecca Miksad
@es
Rebecca Miksad
@sl
type
label
Rebecca Miksad
@ast
Rebecca Miksad
@en
Rebecca Miksad
@es
Rebecca Miksad
@sl
prefLabel
Rebecca Miksad
@ast
Rebecca Miksad
@en
Rebecca Miksad
@es
Rebecca Miksad
@sl
P106
P1153
14056583700
P21
P2798
P31
P496
0000-0003-3194-5122